Growing community of inventors

Ikoma, Japan

Komei Okabe

Average Co-Inventor Count = 4.68

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Komei OkabeKazuhito Yamada (4 patents)Komei OkabeHuey-Ching Su (2 patents)Komei OkabeSreenivasu Mudumba (2 patents)Komei OkabeWeiQi Lin (2 patents)Komei OkabeWilma Tamraz (2 patents)Komei OkabeNaoki Matsumoto (2 patents)Komei OkabeShinji Yoneda (1 patent)Komei OkabeAtsushi Yoshida (1 patent)Komei OkabeToyomi Fujisawa (1 patent)Komei OkabeSae Akao (1 patent)Komei OkabeTatsuya Miyazaki (1 patent)Komei OkabeKenji Masaki (1 patent)Komei OkabeTomomi Kohara (1 patent)Komei OkabeKomei Okabe (5 patents)Kazuhito YamadaKazuhito Yamada (5 patents)Huey-Ching SuHuey-Ching Su (15 patents)Sreenivasu MudumbaSreenivasu Mudumba (15 patents)WeiQi LinWeiQi Lin (7 patents)Wilma TamrazWilma Tamraz (6 patents)Naoki MatsumotoNaoki Matsumoto (4 patents)Shinji YonedaShinji Yoneda (5 patents)Atsushi YoshidaAtsushi Yoshida (4 patents)Toyomi FujisawaToyomi Fujisawa (2 patents)Sae AkaoSae Akao (2 patents)Tatsuya MiyazakiTatsuya Miyazaki (1 patent)Kenji MasakiKenji Masaki (1 patent)Tomomi KoharaTomomi Kohara (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Santen Pharmaceutical Co., Ltd. (5 from 281 patents)

2. Durect Corporation (2 from 93 patents)


5 patents:

1. 11090296 - Sustained-release pharmaceutical composition

2. 10682340 - Depot formulations

3. 10668011 - Depot formulations

4. 9987368 - Pharmaceutical composition comprising polypeptide

5. 9579309 - Prophylactic or therapeutic agent for posterior ocular disease containing tetrahydropyranylaminocyclopentylcarbonyltetrahydropyridopyridine derivative as effective ingredient

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…